Avendus Advises the Shareholders of Devidayal Sales in a Strategic Transaction With Arysta Lifescience.

The promoters, leadership and staff of the Company are very excited to join hands with the Arysta Group, in the formers’ quest to expand the strength of the Devidayal brand beyond the boundaries of India. The deal with Arysta is an endorsement of the quality of the brand and business we have built over the years in the Indian subcontinent. Arysta is extremely supportive of the company’s growth strategy, and we look forward to an exciting future as a member of the Arysta Group of companies.

The Indian agrochemicals industry is growing at 6- 8x times the global average. There is significant potential (and need) to improve crop yields through the use of pesticides, given the demand for food-grains projected over the next 10 years. The management team of Arysta had picked this up based on their deep understanding of global trends in this industry. Given that it takes several years to build and nurture relationships at the field-level in India, an inorganic entry is the most sensible for an MNC looking to enter India. The acquisition of DSL provides Arysta with one of the best launch platforms in India with a large portfolio of product registrations and brands, a highquality sales-and-marketing infrastructure and a production facility with a wide range of formulation and packaging capabilities. Arysta is the most appropriate global partner for the Devidayal team as the latter look to take their brand and products global.